Overview
- Editors:
-
-
Paul L. Wood
-
Pharmacology, CoCensys, Inc., Irvine, USA
Access this book
Other ways to access
Table of contents (14 chapters)
-
-
-
Acute Phase Proteins
-
Front Matter
Pages 127-127
-
- Katharyn Spiegel, Mark R. Emmerling, Scott R. Barnum
Pages 129-176
-
- Joseph Rogers, W. S. T. Griffin
Pages 177-193
-
Cytokines
-
Front Matter
Pages 195-195
-
- David Martin, Gerald Miller, Tim Neuberger, Jane Relton, Norman Fischer
Pages 197-219
-
- Linda Ott, Craig McClain, Stephen Scheff, Jimmi Hatton, Byron Young
Pages 221-249
-
-
Free Radicals
-
Front Matter
Pages 263-263
-
- Kenneth Hensley, Quentin N. Pye, Tahereh Tabatabaie, Charles A. Stewart, Robert A. Floyd
Pages 265-281
-
-
Miscellaneous Mediators
-
Front Matter
Pages 297-297
-
-
-
- Ian W. Rodger, Chi-Chung Chan
Pages 355-371
About this book
An unprecedented review of our current knowledge of the neuroinflammatory mediators and cells involved in neurodegenerative diseases. Beginning with a detailed review of our current concepts of which biochemical mediators are involved in neuronal loss and the mechanisms of cell death, the distinguished contributors critically examine those areas of current research involved in the design of specific pharmacological agents to inhibit at defined points in the neuroinflammatory cascade. They also address the molecular, cellular, and disease model actions of first-generation agents, as well as the potential clinical relevance to AIDS-related dementia, Alzheimer's disease, amyotropic lateral sclerosis (ALS), Down's syndrome, Huntington's disease, multiple sclerosis, Parkinson's disease, and stroke.
Reviews
". . .will reach a wide audience including basic and clinical neuroscientists. . .fills a significant gap in the literature. . .provides an excellent starting point, and offers insight into the rapid pace of discovery within a field which influences most aspects of nervous system function."-Nature Medicine
Editors and Affiliations
-
Pharmacology, CoCensys, Inc., Irvine, USA
Paul L. Wood
